Stryker dives into soft-tissue robotics with $400M play for CMR Surgical’s Versius

Stryker (NYSE: SYK) is diving into soft-tissue robotics with a $400 million investment in CMR […]

Stryker (NYSE: SYK) is diving into soft-tissue robotics with a $400 million investment in CMR Surgical, netting exclusive rights to sell its Versius platform in the U.S. and pocketing an option to acquire the company in the future.

The alliance comes shortly after Medtronic agreed to put $700 million into Cornerstone Robotics and its Sentire system, which it pitched as a complement to its in-house Hugo robot as the company doubles down in its global competition with industry leader Intuitive and newer entrants like Johnson & Johnson.

CMR’s multi-port, cart-based Versius features a modular design that’s angling for easier integration into existing surgical programs and a wider variety of operating room architectures, including outpatient ambulatory surgical centers. The Cambridge, U.K.-based company entered the U.S. market earlier this year, following a 2024 de novo clearance from the FDA.

Read full article: https://www.massdevice.com/stryker-dives-into-soft-tissue-robotics-with-400m-play-for-cmr-surgicals-versius/